Skip to main content
. 2018 Jan 30;5(3):346–356. doi: 10.1002/acn3.534

Figure 2.

Figure 2

Percentage brain volume change from baseline by severity of on‐study disability worsening in the placebo population in patients (A) without* and (B) with evidence of inflammatory activity during the study. *Defined as the absence of relapses and the absence of new or enlarging T2 lesions during the study.